Kite's CAR T-cell Therapy Tecartus® Receives Positive CHMP Opinion in Relapsed or Refractory Acute Lymphoblastic Leukemia Pharmaceutical Investing
CHMP Adopts Positive Opinion Recommending Veklury® Receive Full Marketing Authorization for the Treatment of Patients With COVID-19 Pharmaceutical Investing
Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for LAG-3-Blocking Antibody Combination Opdualag for Treatment of Patients with Unresectable or Metastatic Melanoma Pharmaceutical Investing
Aurinia Announces Positive CHMP Opinion for LUPKYNIS® for the Treatment of Adults with Active Lupus Nephritis in Europe Pharmaceutical Investing
Scientific Innovation and Collaboration Highlighted at AIDS 2022 as Gilead Extends Leadership Efforts Toward Ending the Global HIV Epidemic Pharmaceutical Investing
Bristol Myers Squibb Teams Up with Jack and Jill of America Inc. to Expand Tomorrow's Innovators Program to Increase Black Representation in the Healthcare Industry Pharmaceutical Investing
Jamieson Wellness Inc. Announces Date of Second Quarter 2022 Financial Results and Conference Call Life Science Investing News
Health Canada Approves AbbVie's RINVOQ® for the Treatment of Adults with Active Ankylosing Spondylitis Pharmaceutical Investing
Gilead Sciences Contributes Additional $85 Million to Its Foundation to Advance Health Equity Pharmaceutical Investing
Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance Pharmaceutical Investing
AbbVie and iSTAR Medical Announce Strategic Alliance for the Treatment of Glaucoma Pharmaceutical Investing
Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 45th Annual Growth Conference
